Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes
Year: 2016
Type: article
Authors: Jonathan E. Wilson, Ravi Kurukulasuriya, Christopher Sinz, Matthew Lombardo, Kate Bender, Dann Parker, Edward C. Sherer, Melissa Costa, Karen Dingley, Xiaofang Li, Stanley Mitelman, Sharon Tong, Randal Bugianesi, Anka Ehrhardt, Birgit Priest, Kevin Ratliff, Feroze Ujjainwalla, Ravi Nargund, William K. Hagmann, Scott Edmondson
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2405189531